Last month, US President Donald Trump announced 100% import tariffs on branded and patented pharmaceutical products, making investors jittery. However, this development had little effect on Indian ...

Novartis could lose years of patent protection in the US for its blockbuster multiple sclerosis therapy Gilenya, after a federal appeals verdict went against the company. The litigation revolves ...

Esperion has entered into a settlement agreement with Dr. Reddy’s to resolve the patent litigation in response to Dr. Reddy’s seeking approval to market a generic version of Nexletol and Nexlizet ...

Gilead Sciences' already dominant position in HIV pre-exposure prophylaxis (PrEP) could be extended if the FDA approves a new twice-yearly product later this year. The US regulator has started a ...

Pfizer could hold a Trump card in its bid for Metsera U.S. drugmaker Pfizer could work its connections within President Donald Trump's administration to try to thwart Novo Nordisk's surprise rival bid ...

This annual observance highlights the importance of generic medicines in providing affordable, effective and accessible healthcare to Filipinos. It was held under the theme “Ginhawang Generics, Ramdam ...

F. Hoffmann-La Roche AG on Tuesday moved the Supreme Court against a Delhi High Court's order that allowed Natco Pharma to launch a generic version of the drug Risdiplam in India. Risdiplam is an oral ...

Abstract: The recent Open Radio Access Network (O-RAN) specifications promote the evolution of RAN architecture by function disaggregation, adoption of open interfaces, and instantiation of a ...